What is Amyris?
Amyris operates at the intersection of biotechnology and consumer products, specializing in the conversion of plant sugars into hydrocarbon molecules. This innovative process allows the company to produce a range of specialty ingredients and consumer goods, positioning it as a key player in the sustainable products market. Headquartered in Emeryville, California, with an operational presence in Brazil, Amyris is committed to enabling businesses to achieve growth through environmentally conscious means. The company's core technology focuses on synthetic biology to create high-value molecules for diverse applications.
How much funding has Amyris raised?
Amyris has raised a total of $775.6M across 14 funding rounds:
Debt
$21.7M
Debt
$57.6M
Multiple Rounds
$59.5M
Debt
$19.1M
Multiple Rounds
$317M
Debt
$80M
Debt
$50M
Debt (2014): $21.7M, investors not publicly disclosed
Debt (2015): $57.6M, investors not publicly disclosed
Debt (2016): $20M, investors not publicly disclosed
Debt (2016): $6M, investors not publicly disclosed
Debt (2016): $8.5M, investors not publicly disclosed
Debt (2016): $25M, investors not publicly disclosed
Debt (2017): $19.1M, investors not publicly disclosed
Private Equity (2020): $112M backed by Foris Ventures
Debt (2020): $5M with participation from PPP
Share Placement (2020): $200M, investors not publicly disclosed
Debt (2022): $80M supported by Foris Ventures
Debt (2023): $50M, investors not publicly disclosed
Key Investors in Amyris
Foris Ventures
Foris Ventures is an investment entity that has participated in Amyris's funding rounds, indicating a strategic interest in the company's renewable products and bioscience technology.
PPP
Public-Private Partnership
What's next for Amyris?
The substantial enterprise-level capital infusion suggests Amyris is poised for significant scaling and market expansion. This strategic backing will likely fuel further research and development into novel renewable products, enhance manufacturing capabilities, and broaden its market reach. The company's focus on sustainable hydrocarbon molecules indicates a strategic move towards capturing market share in sectors increasingly prioritizing eco-friendly alternatives. Future growth may involve strategic partnerships and the introduction of new product lines derived from its proprietary bioscience platform.
See full Amyris company page
